Pulmonary hypertension and myocardial function in infants and children with Down syndrome

Area of Science:

• Cardiology
• Genetics
• Pediatrics

Background:

• Down syndrome (DS) is the most frequent chromosomal abnormality in newborns.
• Infants and children with DS face heightened risks of cardiopulmonary conditions, including elevated pulmonary arterial pressures and impaired myocardial function.
• Pulmonary hypertension (PH) in the neonatal period is often underdiagnosed in infants with DS.

Purpose of the Study:

• To review the physiological mechanisms driving PH in children with Down syndrome.
• To summarize current literature on PH and its effects on myocardial performance in this population.
• To emphasize the importance of early PH detection and ongoing screening in at-risk children.

Main Methods:

• Literature review of physiological concepts related to PH in DS.
• Synthesis of available research on PH prevalence and impact in children with DS.
• Analysis of the relationship between PH and myocardial performance.

Main Results:

• PH occurs with or without congenital heart defects in children with DS.
• PH is more prevalent in children with DS than in the general population.
• PH significantly impacts myocardial performance and cardiac function.

Conclusions:

• Early recognition and consistent screening for PH are crucial for children with Down syndrome.
• Prompt intervention can mitigate long-term cardiac sequelae.
• Understanding PH mechanisms is key to managing cardiopulmonary risks in DS.